• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: BB Biotech     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.org associated with source document(s)

Type: Thingcompanyschema:Organizationdul:Agentdul:SocialPersonagentwikidata:Q24229398OrganizationBusiness enterpriseyago:WikicatBiotechnologyCompaniesyago:WikicatCompaniesEstablishedIn1993yago:WikicatCompaniesListedOnTheBorsaItalianayago:WikicatCompaniesListedOnTheFrankfurtStockExchangeyago:Abstraction100002137yago:Company108058098yago:FinancialInstitution108054721yago:Group100031264yago:Institution108053576yago:InvestmentCompany108070850yago:NondepositoryFinancialInstitution108419984yago:Organization108008335yago:WikicatInformationTechnologyCompaniesOfSwitzerlandyago:WikicatInvestmentCompaniesOfSwitzerlandyago:YagoLegalActoryago:YagoLegalActorGeoyago:YagoPermanentlyLocatedEntityorganisationyago:SocialGroup107950920 New Facet based on Instances of this Class

BB Biotech AG is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana. The company invests mainly in the United States and Western Europe. BB Biotech is managed by Bellevue Asset Management, a division of Bellevue Group and accounts for approximately 40% of the Group's Assets Under Management.